Zuoming Luo
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Medical Imaging Techniques and Applications 6
- Radiomics and Machine Learning in Medical Imaging 4
- Surgery 7
- Esophageal Cancer Research and Treatment 5
- Co-authors
- Long Sun (15 shared papers)Hua Wu (9 shared papers)Haojun Chen (5 shared papers)Qin Lin (7 shared papers)Yizhen Pang (4 shared papers)Liang Zhao (3 shared papers)Bing Hao (4 shared papers)Long Zhao (10 shared papers)
In The Last Decade
Zuoming Luo
16 papers receiving 875 citations
Zuoming Luo's Hit Papers
Peers
Comparison fields: 5 of 45
- Cancer Research 438
- Oncology 679
- Radiology, Nuclear Medicine and Imaging 258
- Surgery 450
- Cellular and Molecular Neuroscience 110
Countries citing papers authored by Zuoming Luo
This map shows the geographic impact of Zuoming Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuoming Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuoming Luo more than expected).
Fields of papers citing papers by Zuoming Luo
This network shows the impact of papers produced by Zuoming Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuoming Luo. The network helps show where Zuoming Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Zuoming Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer Hit paper breakdown → | 2020 | 398 |
| 2 | 2020 | 197 | |
| 3 | 2021 | 101 | |
| 4 | 2016 | 39 | |
| 5 | 2008 | 35 | |
| 6 | 2014 | 30 | |
| 7 | 2008 | 28 | |
| 8 | Value of sequential 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in prediction of the overall survival of esophageal cancer patients treated with chemoradiotherapy. | 2015 | 19 |
| 9 | 2018 | 14 | |
| 10 | 2009 | 11 | |
| 11 | Comparison of dual-source parallel radio frequency transmission liver MRI at 3.0 T with conventional MRI. | 2013 | 2 |
| 12 | 2010 | 2 | |
| 13 | 2013 | 1 | |
| 14 | 2014 | 1 | |
| 15 | Application of sequential (18)F-FDG PET/CT scans for concurrent chemoradiotherapy of non-surgical squamous cell esophageal carcinoma. | 2014 | 1 |
| 16 | 2012 | 1 |
About Zuoming Luo
Zuoming Luo is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 16 papers that have together received 880 indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (6 papers), Esophageal Cancer Research and Treatment (5 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Gastric Cancer Management and Outcomes (4 papers), Peptidase Inhibition and Analysis (3 papers), Medical Imaging and Pathology Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Cardiac tumors and thrombi (2 papers). The work is most often cited by research in Cancer Research (438 citations), Oncology (679 citations), Radiology, Nuclear Medicine and Imaging (258 citations), Surgery (450 citations) and Cellular and Molecular Neuroscience (110 citations). Zuoming Luo has collaborated with scholars based in China, Japan and Türkiye. Frequent co-authors include Long Sun, Hua Wu, Haojun Chen, Qin Lin, Yizhen Pang, Liang Zhao, Bing Hao, Long Zhao, Jihong Wei and Jing Wu. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, World Journal of Gastroenterology, Radiology, BMC Cancer and Nuclear Medicine Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.